Fujirebio & Agappe ink business collaboration for CLIA based immunoassay products

Contract Manufacturing |  News | 0 Comment | 22 Jan, 2024

Japan-based Fujirebio Holdings and Indian firm Agappe Diagnostics have entered into an agreement of Contract Development...Read more

Taiwan's Bora Pharma acquires US-based Upsher-Smith for $210 M to fuel global expansion

Contract Manufacturing |  News | 0 Comment | 19 Jan, 2024

Taiwan-based Bora Pharmaceuticals announced that its Board of Directors has approved the acquisition of Upsher-Smith L...Read more

China's WuXi Biologics announces research service agreement worth $20 M with BioNTech

Contract Manufacturing |  News | 0 Comment | 11 Jan, 2024

China's WuXi Biologics has signed a research service agreement with Germany-based BioNTech SE, a next generation immunot...Read more

“Pharma companies in South Korea will need to invest in skill development”

Contract Manufacturing |  Opinion | 0 Comment | 05 Jan, 2024

How is the contract manufacturing/development sector evolving in Korea? How is West leveraging opportunities in this spa...Read more

AGC invests 50 Billion Yen to expand biopharmaceutical CDMO capability in Japan

Contract Manufacturing |  News | 0 Comment | 26 Dec, 2023

AGC Inc, Japan-headquartered manufacturer of glass, chemicals, and high-tech materials, has decided to expand its biopha...Read more

Fujifilm invests $200 M into cell therapy development and manufacturing capabilities in US

Contract Manufacturing |  News | 0 Comment | 08 Dec, 2023

Japan-headquartered Fujifilm Corporation has announced the investment of $200 million in two subsidiaries to significant...Read more

Aragen to invest $30 M for new bio-manufacturing site in India

Contract Manufacturing |  News | 0 Comment | 30 Oct, 2023

Aragen, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics...Read more

Korean firm Samsung Biologics to further expand footprint into European market

Contract Manufacturing |  News | 0 Comment | 24 Oct, 2023

Samsung Biologics, South Korea-based contract development and manufacturing organisation (CDMO), and Kurma Partners, a E...Read more

WuXi XDC and HKSTP promote development of bioconjugate drug industry in Hong Kong

Contract Manufacturing |  News | 0 Comment | 19 Oct, 2023

WuXi XDC, a China-based Contract, Research, Development, Manufacturing Organisation (CRDMO) focused on the antibody drug...Read more

Thermo Fisher expands manufacturing facility in US for complex biologic treatments

Contract Manufacturing |  News | 0 Comment | 06 Oct, 2023

Thermo Fisher Scientific has expanded its manufacturing capacity in St. Louis, US to support biologic therapies for dise...Read more

Lotte Biologics to establish three new bio plants in Korea by 2030

Contract Manufacturing |  News | 0 Comment | 05 Oct, 2023

Lotte Biologics has signed a land purchase agreement with the Incheon Free Economic Zone Authority (IFEZ) for the establ...Read more

WuXi unveils first vaccines CDMO site in China

Contract Manufacturing |  News | 0 Comment | 27 Sep, 2023

WuXi Vaccines, a leading contract development and manufacturing organisation (CDMO) focused on vaccine discovery, develo...Read more

Chinese startup Canton Biologics completes 300+ M Yuan series C financing

Contract Manufacturing |  News | 0 Comment | 19 Sep, 2023

China-based startup Canton Biologics recently completed a Series C financing round exceeding 300 million yuan. This roun...Read more

Cytiva expands scientific, digital, and training offering in China

Contract Manufacturing |  News | 0 Comment | 18 Sep, 2023

Recognising the long-term needs of the biopharma industry in China and Asia-Pacific, global life sciences leader Cytiva ...Read more

Korea's Samsung Biologics expands oncology agreement with Bristol Myers Squibb

Contract Manufacturing |  News | 0 Comment | 18 Sep, 2023

South Korea-based Samsung Biologics has announced a new agreement with Bristol Myers Squibb (BMS) for large-scale manufa...Read more

Europe opens largest manufacturing facility for microbiome ecosystem therapies

Contract Manufacturing |  News | 0 Comment | 12 Sep, 2023

MaaT Pharma, a clinical-stage biotech company and a leader in the development of Microbiome Ecosystem Therapies (ME...Read more

BIO Asia-Taiwan 2023: Embracing Asian Dynamics around precision health and CDMO

Contract Manufacturing |  Analysis | By Hithaishi C Bhaskar | 0 Comment | 31 Aug, 2023

The Taiwan Bio Industry Organization (Taiwan BIO) and the global Biotechnology Innovation Organization (BIO) ignited Tai...Read more

China's T-Maximum Biotech selects GenScript CRISPR reagents to target high-grade gliomas

Contract Manufacturing |  News | 0 Comment | 10 Aug, 2023

US-based GenScript Biotech, and China-based startup T-Maximum Biotech, a biotechnology company pioneering universal...Read more